Popular diabetes drugs Invokana, Farxiga, and Jardiance can raise kidney and bladder cancer risk, the risk of ketoacidosis, and the risk of genital amputations. First introduced in 2013, these SGL2 inhibitors are supposed to

The US FDA announced on August 29, 2018 that certain diabetes drugs can cause dangerous genital infections.  The agency warned that people suffering from type 2 diabetes can be injured by a terrible “side

(Sept. 24, 2018)  Diabetes drugs can cause Fournier’s gangrene.  That was the shocking conclusion of the FDA last month after the agency said it received reports that 12 people contracted gangrene or necrotizing fasciitis

(August 30, 2018)   Invokana and other diabetes drugs like Farxiga and Jardiance can cause a flesh-eating bacterial infection in the genitals.  The U.S. FDA warned doctors and patients yesterday about the risk of

The diabetes drug Invokana raises the risk of foot and leg amputations. As a result, the FDA required Johnson & Johnson to add new warnings to the Invokana drug label in 2017. The agency

(March 5, 2018) – Invokana drug amputations have prompted two new lawsuit filings. Lawsuits were filed last month in New Jersey for two people who lost a leg below the knee after using Invokana.  The

Invokana dangers were seen early on by researchers. FDA reviewers were divided over the safety and effectiveness of Invokana before approving it for the market in 2013. At that time, the agency acted against

FDA reviewers  expressed concern over the safety and efficacy of Invokana before voting to approve it for sale. In fact, just 67% of them decided that letting Invokana hit the market was a good

Invokana warnings were strengthened by FDA June 14, 2016. The announcement topped the existing FDA warning made May 18, 2016. The agency wrote that recent reports prompted it to revise the warnings on Invokana’s

An Invokana $1 billion lawsuit was filed against J&J's Janssen Inc. in Canada in September 2015. The petition alleges patients suffered serious Invokana side effects, and seeks class-action status. Ontario resident Rosalba Joudry alleges

The FDA announced May 18, 2016 that Invokana increased the risk of leg and foot amputations in a clinical study. The agency alerted the public that the diabetes medicine canagliflozin (Invokana, Invokamet) increased amputations

Patients in a clinical trial taking Invokana and Invokamet were roughly twice as likely to suffer amputations as patients taking placebo. The U.S. FDA reported the clinical trial results May 18, 2016 on Janssen

You might consider the drugs you take safe if they’ve been approved by the FDA; but recent history should give you pause. The FDA has approved more than a dozen drugs in recent years which

The FDA is investigating whether diabetes medicine is linked to ketoacidosis. The agency issued a warning in May 2015 that people taking Invokana and other diabetes medications may suffer ketoacidosis, a serious health problem